CD40LG and hepatocellular carcinoma: For example, experimental evidence demonstrated that only IgM antibodies, especially clone M6-1D4, significantly reduce the viability of hepatocellular carcinoma (HCC) cell lines by inducing RIPK-independent necroptosis, while the IgG antibodies were ineffective (41).